Show results for
Refine by
Patient Metastatic Disease Equipment Supplied In Canada
7 equipment items found
Manufactured by:Precision For Medicine, Inc. based inFrederick, MARYLAND (USA)
Clinical and research-grade leukopaks - mobilized or non-mobilized from healthy and diseased subjects, including oncology donors. ...
Manufactured by:TSI Incorporated based inShoreview, MINNESOTA (USA)
To limit the spread of disease through a facility, patients suspected of having diseases spread through the air must be placed in negative pressure rooms, airborne infection isolation rooms. Similarly, immune-compromised patients at risk of contracting diseases should stay in positive pressure, protective environment rooms. PRESSURA™ room pressure controls continuously monitor room pressure ...
Manufactured by:Augurex Life Sciences Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
Citrullination is a highly relevant post-translational modification of proteins that occurs in RA and certain other conditions. In the extracellular space, 14-3-3η becomes citrullinated (cit) in the presence of peptidylarginine deiminases (PAD) enzymes and this extracellular modified form of the protein, cit-14-3-3η, also elicits an auto-immune response that generates cit-14-3-3η ...
Manufactured by:Augurex Life Sciences Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
14-3-3η is not normally present outside of cells. Therefore, in the disease state, the body views it as foreign and mounts an immune response in an attempt to clear it. This immune response generates14-3-3η specific auto-antibodies that are measureable in blood and provide complementary disease information to the 14-3-3η protein. In particular, they are highly specific in very early ...
Manufactured by:Augurex Life Sciences Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
In the development of RA and other inflammatory types of arthritis, multiple factors contribute to disease processes to varying degrees in different patients. 14-3-3η is recognized as a new factor within this process and represents a rationale drug target for personalized medicine alongside its 14-3-3η companion biomarker portfolio described above. Augurex preclinical animal studies to ...
Manufactured by:Augurex Life Sciences Corp. based inVancouver, BRITISH COLUMBIA (CANADA)
Extracellular 14-3-3η protein is a potent ligand and activator of intracellular signalling pathways that lead to the up-regulation of inflammation and joint damage factors involved in RA pathogenesis. The 14-3-3η blood test is clinically available as a diagnostic test whereby a positive result indicates a 5 to 50 times greater likelihood of having RA and informs joint damage prognosis and ...
Manufactured by:KI Canada Ltd. based inPeterborough, ONTARIO (CANADA)
Demron is Certified Against the Coronavirus RST Demron Apparel is Certified Against the Coronavirus Radiation Shield Technologies offers ...